spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  SEGA 

 HSMN NewsFeed - 20 Jan 2022
Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer
Devices Oncology
 HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Oct 2020
Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business
Devices Dermatology Acquisitions
 HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2020
F1 Oncology Changes Name To EXUMA Biotech; Announces New Round Of Financing To Advance Cellular Therapies
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 31 Jan 2020
Olympus Announces FDA Clearance of the TJF-Q190V Duodenoscope
Devices Gastroenterology FDA
 HSMN NewsFeed - 24 Jan 2020
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Devices Neurology FDA
 HSMN NewsFeed - 26 Jun 2019
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2018
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
Devices Neurology Venture Capital
 HSMN NewsFeed - 14 May 2018
CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System
Devices Radiology Orthopaedic FDA
 HSMN NewsFeed - 10 Nov 2017
Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate(R) (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Dec 2016
Biogen Names Michel Vounatsos Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2016
Biogen Appoints Michel Vounatsos Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Dec 2015
Braeburn Pharmaceuticals and Camurus Enroll First Patient in a Phase 3 Efficacy Trial of Long-acting Treatment for Opioid Dependence
Biopharmaceuticals
 HSMN NewsFeed - 14 Jul 2015
Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jun 2014
Ligand Partner GSK Announces Results of Phase 3 PETIT2 Study of Eltrombopag (Promacta(TM)/Revolade(TM)) in Pediatric Patients with Chronic Immune Thrombocytopenia
Biopharmaceuticals
 HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2013
New Toshiba Ultrasound Technology Shows Blood Flow Like Never Before
Devices Radiology
 HSMN NewsFeed - 28 Jun 2013
Toshiba Cardiac Ultrasound Improves Visualization, Diagnostic Accuracy
Devices Cardiology Radiology
 HSMN NewsFeed - 8 Mar 2013
Toshiba Launches New Cardiac Ultrasound Systems at ACC
Devices Cardiology
 HSMN NewsFeed - 4 Mar 2013
CIS is First Cardiac Center to Install 10 Toshiba Aplio 500 Ultrasound Systems
Devices Radiology Cardiology
 HSMN NewsFeed - 10 Jan 2013
Brainsway Receives FDA Approval
Devices Neurology FDA
 HSMN NewsFeed - 28 Nov 2012
Toshiba Brings Back Industry’s Best Ultrasound Warranty Program
Devices Radiology
 HSMN NewsFeed - 26 Nov 2012
New and Future Innovations for Toshiba Ultrasound Improve Image Quality and Workflow
Devices Radiology
 HSMN NewsFeed - 25 Sep 2012
Toshiba Expands Assurance Program to Ultrasound
Devices
 HSMN NewsFeed - 20 Aug 2012
Asante Installs 15 Toshiba Ultrasound Units
Devices Radiology
 HSMN NewsFeed - 17 Jul 2012
Thomas Jefferson University Pilot Study Finds Toshiba’s Ultrasound Technology Helps Improve Breast Microcalcification Visualization
Devices Radiology
 HSMN NewsFeed - 11 Jul 2012
Toshiba’s Smart Fusion Technology Helps Make Interventional Procedures Safer and More Accurate
Devices Radiology
 HSMN NewsFeed - 11 Jun 2012
Toshiba Partners with United Medical Instruments to Distribute Ultrasound Systems
Devices Distribution
 HSMN NewsFeed - 22 Mar 2012
Toshiba’s Newest Ultrasound Systems Offer Breakthrough Imaging Technologies and Advanced Cardiac Capabilities
Devices Cardiology
 HSMN NewsFeed - 8 Feb 2012
Toshiba Installs First Aplio 500 Ultrasound System at Spectrum Health
Devices
 HSMN NewsFeed - 18 Jan 2012
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Biopharmaceuticals
 HSMN NewsFeed - 30 Sep 2011
Takeda Completes Acquisition and Names New CEO of Nycomed
Biopharmaceuticals Personnel Mergers & Acquisitions
 HSMN NewsFeed - 8 Jul 2011
Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2011
Takeda to Acquire Nycomed
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Apr 2011
Toshiba Introduces Enhancements on Its Ultrasound Product Line to Improve Cardiac Diagnostic Capabilities
Devices Cardiology
 HSMN NewsFeed - 16 Feb 2011
Toshiba Announces FDA Clearance of Auto-IMT Ultrasound Software
Devices FDA
 HSMN NewsFeed - 9 Dec 2010
Study Shows Novartis Drug Afinitor(R) Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Dec 2010
Toshiba Enhances Aplio XG with Women’s Imaging Configuration Designed to Improve Breast and High-Risk OB/GYN Imaging
Devices Radiology
 HSMN NewsFeed - 3 Nov 2010
Study in NEJM Shows Novartis Drug Afinitor(R) Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2010
Novartis Drug Afinitor(R) Approved by FDA as First Medication for Children and Adults with a Benign Brain Tumor Associated with Tuberous Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Oct 2010
Toshiba Ultrasound Systems Improve Workflow at University Hospitals Case Medical Center
Devices
 HSMN NewsFeed - 20 Sep 2010
Toshiba Ultrasound Improves Imaging Consistency across Departments at Florida Hospital Fish Memorial
Devices
 HSMN NewsFeed - 17 Jun 2010
Toshiba Names Tomo Hasegawa Director of Ultrasound Business Unit
Devices Personnel
 HSMN NewsFeed - 22 Apr 2010
Delcath Systems Appoints Peter J. Graham as Executive Vice President and General Counsel
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 9 Jun 2009
Thallion Announces Changes to Management and Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 May 2008
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
Takeda Completes Acquisition of Millennium
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2008
Takeda Announces New U.S. Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2008
Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2008
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Nov 2007
Helix BioPharma Corp. announces management changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2007
Thallion Provides Update on Shigamabs(R) Clinical Development and U.S. Regulatory Plan
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2007
Teva Provides Update on Edratide for Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 16 Aug 2007
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 25 Apr 2007
Thallion Pharmaceuticals Inc. Hires Executive Vice-President, Licensing and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2007
Takeda to Acquire Paradigm Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Feb 2007
ThermoGenesis Corp. Names Cell Therapy Device Sales Expert Daniel A. Segal as Vice President of Sales & Marketing
Devices Personnel
 HSMN NewsFeed - 4 Jan 2007
Ecopia Announces Agreement with Caprion to Combine their Businesses and Launch a $30 Million Private Placement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2006
Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to Amrubicin for North America and the European Union
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2006
Study Results Found Low-Dose Orlistat (60 mg) Demonstrates Significant Reduction in LDL Cholesterol While Providing Weight Loss for Up to Two Years
Biopharmaceuticals
 HSMN NewsFeed - 9 Oct 2006
GlaxoSmithKline to Acquire CNS, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2006
Xenon and Takeda Announce Agreement To Develop and Commercialize XEN401 for Pain in Japan and Certain Asian Countries
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 32

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 32 additional stories matching:
SEGA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.